| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 56,3 k € | +21.9% | 46,2 k € | ||||||||||||||||||
| Gross margin | 131,5 k € | +61.1% | 81,6 k € | -16.1% | 97,3 k € | +37.8% | 70,6 k € | +53.0% | 46,2 k € | -37.2% | 73,5 k € | -3.6% | 76,2 k € | -0.6% | 76,7 k € | -12.3% | 87,5 k € | +2.6% | 85,2 k € | -4.8% | 89,5 k € | +18.2% | 75,8 k € | +13.8% | 66,6 k € | -2.4% | 68,2 k € | +26.9% | 53,7 k € | +17.8% | 45,6 k € | +10.6% | 41,3 k € | -10.4% | 46,0 k € | +33.5% | 34,5 k € | |
| EBITDA | 126,5 k € | +73.2% | 73,0 k € | -20.7% | 92,0 k € | +35.8% | 67,8 k € | +56.1% | 43,4 k € | -38.6% | 70,7 k € | -4.4% | 73,9 k € | -0.5% | 74,3 k € | -12.8% | 85,3 k € | +2.8% | 83,0 k € | -5.1% | 87,4 k € | +21.6% | 71,9 k € | +9.6% | 65,6 k € | -2.4% | 67,3 k € | +28.0% | 52,6 k € | +18.2% | 44,5 k € | +11.0% | 40,1 k € | -10.3% | 44,7 k € | +38.4% | 32,3 k € | |
| Operating profit | 68,7 k € | +990.8% | 6,3 k € | -74.9% | 25,1 k € | +271.8% | 6,8 k € | +129.1% | -23,2 k € | -593.4% | 4,7 k € | -76.8% | 20,3 k € | -1.1% | 20,5 k € | -39.9% | 34,1 k € | +4.6% | 32,5 k € | -27.0% | 44,6 k € | +53.3% | 29,1 k € | +11.8% | 26,0 k € | -29.1% | 36,7 k € | +56.3% | 23,5 k € | +50.3% | 15,6 k € | +44.3% | 10,8 k € | -34.4% | 16,5 k € | +46.8% | 11,3 k € | |
| Profit/loss | 55,1 k € | +1799.8% | 2,9 k € | -86.3% | 21,2 k € | +658.5% | 2,8 k € | +110.8% | -25,9 k € | -3591.7% | 743,0 € | -92.8% | 10,3 k € | +17.3% | 8,8 k € | -46.5% | 16,5 k € | +7.5% | 15,3 k € | -30.0% | 21,9 k € | +76.3% | 12,4 k € | +25.5% | 9,9 k € | -37.9% | 15,9 k € | +148.3% | 6,4 k € | +389.6% | -2,2 k € | +53.5% | -4,8 k € | -287.9% | 2,5 k € | -90.5% | 26,7 k € | |
| Equity | 230,4 k € | +31.4% | 175,3 k € | +1.7% | 172,4 k € | +14.0% | 151,2 k € | +1.9% | 148,4 k € | -14.9% | 174,3 k € | +0.4% | 173,6 k € | +6.3% | 163,2 k € | +5.7% | 154,4 k € | +11.9% | 138,0 k € | +12.5% | 122,7 k € | +21.7% | 100,8 k € | +14.0% | 88,4 k € | +12.6% | 78,5 k € | +25.4% | 62,6 k € | +11.4% | 56,2 k € | -3.8% | 58,4 k € | -7.5% | 63,2 k € | +4.2% | 60,7 k € | |
| Total assets | 684,0 k € | +2.6% | 666,9 k € | -6.9% | 716,3 k € | -4.8% | 752,1 k € | +145.5% | 306,4 k € | -17.4% | 370,7 k € | +2.9% | 360,2 k € | -12.1% | 409,5 k € | -10.2% | 455,9 k € | -7.3% | 491,5 k € | +16.6% | 421,7 k € | -6.9% | 452,7 k € | -5.6% | 479,5 k € | +16.3% | 412,2 k € | -2.9% | 424,6 k € | -3.9% | 442,0 k € | -5.8% | 469,3 k € | -4.5% | 491,5 k € | +14.0% | 431,2 k € | |
| Cash | 37,7 k € | +1260.0% | 2,8 k € | -50.3% | 5,6 k € | -75.4% | 22,8 k € | +554.7% | 3,5 k € | -61.7% | 9,1 k € | +569.5% | 1,4 k € | -56.0% | 3,1 k € | -73.2% | 11,5 k € | +295.4% | 2,9 k € | -77.2% | 12,8 k € | +498.9% | 2,1 k € | -89.1% | 19,4 k € | +222.3% | 6,0 k € | +143.6% | 2,5 k € | — | 1,6 k € | +371.1% | 339,0 € | -98.2% | 18,8 k € | |||
| Debts | 443,4 k € | -9.8% | 491,7 k € | -9.6% | 543,9 k € | -9.5% | 600,9 k € | +280.3% | 158,0 k € | -19.5% | 196,4 k € | +5.7% | 185,9 k € | -24.3% | 245,6 k € | -18.3% | 300,7 k € | -14.9% | 353,5 k € | +18.2% | 299,0 k € | -15.0% | 351,9 k € | -10.0% | 391,1 k € | +17.2% | 333,7 k € | -7.8% | 361,9 k € | -6.2% | 385,8 k € | -6.1% | 410,9 k € | -4.0% | 427,9 k € | +15.5% | 370,5 k € | |
Private limited company · Braine-le-Comte · incorporated on 30/08/1999
Private limited company profitable and well capitalised. Cash position rising (+1260.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CODEVET is a Private limited company incorporated in 1999. Its main activity is: Veterinary activities. Its registered office is in Braine-le-Comte.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette